Mastering Balloon Atrial Septostomy: Procedure, Indications, Risks, and Benefits — Cost, Top Hospitals & Success Rates | MyMedicPlus

Balloon atrial septostomy (BAS), also known as the Rashkind procedure, is a catheter-based cardiac intervention that creates or enlarges an opening between the left and right atria by inflating a balloon and rapidly withdrawing it across the atrial septum. The technique was first described by William Rashkind and William Miller in 1966 and revolutionised the immediate management of critical cyanotic congenital heart disease, particularly d-transposition of the great arteries (d-TGA).

The procedure is performed in the cardiac catheterisation laboratory or at the bedside in the neonatal intensive care unit. Under echocardiographic guidance (or fluoroscopy), a balloon catheter (typically a Miller or Rashkind balloon catheter) is introduced via the umbilical vein or femoral vein, advanced through the right atrium, and passed through the foramen ovale or patent foramen ovale into the left atrium. The balloon is inflated to a volume of 2-4 ml and then forcefully jerked back across the septum, tearing the fossa ovalis and creating a non-restrictive interatrial communication.

The immediate haemodynamic effect is to allow bidirectional mixing of oxygenated blood from the pulmonary veins and deoxygenated blood from the systemic veins at the atrial level, increasing systemic oxygen saturation from below 60% to 75-85% within minutes. This life-saving manoeuvre buys time for the neonate to stabilise before transport to a tertiary centre and scheduling of the arterial switch operation within the first 2-4 weeks of life.

Echocardiographic assessment of the resulting defect size and haemodynamic impact is performed immediately after balloon withdrawal. An adequate interatrial communication is defined as a defect diameter of at least 5-8 mm with unrestricted Doppler flow. If the initial result is inadequate, the balloon is re-advanced and the manoeuvre repeated with a larger balloon or additional pulls.

d-Transposition of the great arteries (d-TGA) is the primary indication, accounting for the vast majority of BAS procedures. In d-TGA, the aorta arises from the morphological right ventricle and the pulmonary artery from the morphological left ventricle, creating parallel rather than in-series circulations. Oxygenated blood returns to the lungs, and deoxygenated blood recirculates systemically. Without adequate mixing through an interatrial, interventricular, or ductal communication, the neonate rapidly develops profound cyanosis and metabolic acidosis within 24-72 hours of birth.

Secondary indications include total anomalous pulmonary venous connection (TAPVC) with a restrictive atrial septum causing severe pulmonary hypertension, hypoplastic left heart syndrome (HLHS) when the atrial communication is restrictive and is preventing forward flow into the left-sided cardiac chambers, and critical mitral stenosis or cor triatriatum with refractory pulmonary oedema. In adult patients, BAS may be performed for severe pulmonary arterial hypertension refractory to maximal medical therapy, though this indication requires more controlled gradual dilation techniques.

Neonates with d-TGA presenting with oxygen saturation below 75% on maximal medical therapy (prostaglandin E1, supplemental oxygen) and echocardiographic evidence of a restrictive interatrial communication (Doppler gradient across the atrial septum above 5 mmHg, defect diameter below 4 mm) are the primary candidates for emergency BAS. The procedure is considered before or en route to the cardiac catheterisation laboratory depending on the severity of hypoxaemia.

Relative contraindications include a neonate who is too small for available catheter systems, an already adequate (non-restrictive) interatrial communication visible on echocardiography making the procedure unnecessary, and severe coagulopathy uncorrected prior to vascular access. In neonates with TAPVC, BAS carries a risk of worsening haemodynamics if the obstructed pulmonary veins are not simultaneously relieved, and urgent surgical repair may be preferred instead.

Classic balloon atrial septostomy using Rashkind or Miller balloon catheters (2.5-4.0 cm balloon diameter) is performed by inflating the balloon in the left atrium and rapidly jerking it back across the septum with a single decisive motion. The manoeuvre may be repeated 2-4 times until the desired defect size is achieved and confirmed by echocardiography. Multiple sequential pulls with gradual balloon size escalation optimise the result while minimising trauma.

Blade atrial septostomy (Park blade catheter) is an alternative for patients over 3-4 weeks of age whose atrial septum is thicker and more fibrotic, making balloon tearing ineffective. The retractable blade incises the septum in multiple passes before balloon dilation enlarges the incision. Static balloon dilation — sequential dilation of a transseptal puncture with progressively larger balloons (up to 20-30 mm diameter) — is preferred for older children and adults with PAH, as it allows precise size control. Radiofrequency perforation creates a controlled opening in an intact septum when the foramen ovale is already closed. The treating surgeon individualises the chosen technique based on patient anatomy, the extent and nature of the underlying condition, available equipment, and the balance of procedural benefit against risk — a decision made in consultation with the patient following a thorough informed consent discussion covering all available options.

Balloon atrial septostomy in neonates with d-TGA produces rapid and dramatic improvement in oxygen saturation — from below 60% to 75-90% in most cases — within minutes of the procedure. This stabilisation enables safe medical management, transport to a tertiary cardiac centre, and planning of the arterial switch operation, which is then performed with mortality below 2-5% at high-volume centres. The long-term outcome of arterial switch operation following successful BAS is excellent, with 20-year survival exceeding 85-90%.

In adults with PAH, BAS improves cardiac index by 30-50%, reduces right atrial pressure, decreases frequency of syncopal episodes, and improves WHO functional class in 50-70% of patients. Registry data demonstrate improved survival compared to continued medical therapy alone in appropriately selected PAH patients. The procedure is not curative in PAH but provides meaningful palliative benefit.

The most serious immediate complication is cardiac tamponade from perforation of the atrial wall, which may occur from aggressive balloon traction or inadvertent aortic root perforation. This life-threatening complication requires emergency pericardiocentesis or surgical drainage. Paradoxical air embolism causing coronary occlusion or stroke can occur if air enters the balloon system. Balloon rupture within the heart is rare but can occur with overinflation or catheter defects, potentially requiring surgical retrieval.

Arrhythmias, particularly supraventricular tachycardia and transient AV block, may occur during catheter manipulation and typically resolve spontaneously. Mitral valve injury from aggressive balloon withdrawal is a rare but serious complication. In adults with PAH, the primary risk is fatal acute hypoxaemia from over-large septal communication causing excessive right-to-left shunting — procedural mortality in PAH is 5-15%.

Following BAS in neonates, echocardiography within 6-12 hours of the procedure confirms adequacy of the interatrial communication and haemodynamic stability. The neonate is maintained on prostaglandin E1 infusion to ensure ductal patency and optimal pulmonary-to-systemic mixing. Arterial switch operation is typically planned within 2-4 weeks of BAS, before the left ventricle becomes de-conditioned due to low-pressure pulmonary circulation.

Laboratory monitoring includes serial blood gas analysis to track improvement in pH and base excess, complete blood count for post-procedural haemolysis, and electrolytes. Parental counselling regarding the planned surgical procedure, realistic expectations, and cardiac intensive care stay is an essential component of post-procedure management.

Balloon atrial septostomy as a standalone procedure costs $15,000-$30,000 in the United States when including neonatal ICU time and catheterisation laboratory fees. When performed as part of neonatal emergency management prior to cardiac surgery, it is incorporated into the total episode of care cost, which may reach $150,000-$300,000 for complete d-TGA management including arterial switch operation.

In India, Turkey, and Thailand, the BAS procedure and subsequent arterial switch operation at JCI-accredited centres costs $8,000-$20,000 total, representing substantial savings. Countries such as India host world-class paediatric cardiac surgery centres (Narayana Health, AIIMS, Apollo) with high surgical volumes and published outcomes comparable to international benchmarks. Families considering medical tourism for neonatal cardiac surgery should evaluate centre NICU capacity, paediatric cardiac surgery volume, and post-discharge follow-up protocols.

Prostaglandin E1 (alprostadil) infusion, which maintains ductal patency and augments mixing of blood at the ductal level, is the primary medical temporising measure in d-TGA neonates prior to or instead of BAS. In some stable neonates with adequate spontaneous mixing through a patent foramen ovale, early arterial switch operation without prior BAS is feasible and is the approach at some centres that prefer immediate definitive correction.

For TAPVC with restrictive septum, emergency surgical repair of the anomalous pulmonary venous drainage is the definitive treatment, and BAS may be used only as an extremely brief bridge in the most unstable patients. For PAH, lung transplantation or heart-lung transplantation offers definitive cure where organ availability and patient fitness allow.